Publication | Closed Access
Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group
53
Citations
24
References
2011
Year
Hoosier Oncology GroupWeekly TopotecanMedicineGynecologyRecurrent Ovarian CancerCancer TreatmentOncologyRadiation OncologyMolecular OncologyEndocrine-related CancerOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1